| Literature DB >> 25749933 |
Thomas Jozefiak1,2, Nanna Sønnichsen Kayed3, Tormod Rimehaug3, Anne Kristine Wormdal4, Ann Mari Brubakk5,6, Lars Wichstrøm7.
Abstract
Most adolescents are placed in residential youth care (RYC) because of severe psychosocial strains and child maltreatment, which represent risk factors for developing mental disorders. To plan RYC units and ensure that residents receive evidence-based psychiatric interventions, it is necessary to obtain reliable and valid prevalence estimates of mental disorders in this population. However, there is a lacuna of research on diagnoses derived from standardized clinical interviews. The aim of this study was to assess the prevalence and comorbidity of mental disorders applying diagnostic interviews in an entire population of adolescents living in RYC in Norway. All young people in RYC were invited to participate in the study. Eighty-six RYC institutions with 601 eligible adolescents were included and 400 adolescents, 12-20 years old, participated in the study, yielding a response rate of 67 %. Anonymous Child Behaviour Checklist scores for 141 (70 %) of the declining residents were also available, allowing diagnoses according to the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) for 541 youths to be estimated. Diagnoses were assessed by trained interviewers with the Child and Adolescent Psychiatric Assessment interview (CAPA). Seventy-six point two per cent (71.5-80.8 CI 95 %) of adolescents received at least one 3-month DSM-IV diagnosis. Prevalence rates for internalizing psychiatric disorders were higher than for behavioural disorders. Comorbidity was high between these two groups. Mental disorders were prevalent among children and youth in RYC. Our results create major concerns and challenge the existing organization of the RYC system.Entities:
Keywords: Adolescents; CAPA; Comorbidity; Mental disorders; Prevalence; Residential youth care
Mesh:
Year: 2015 PMID: 25749933 PMCID: PMC4698296 DOI: 10.1007/s00787-015-0700-x
Source DB: PubMed Journal: Eur Child Adolesc Psychiatry ISSN: 1018-8827 Impact factor: 4.785
Fig. 1Inclusion flowchart. CAPA Child and Adolescent Assessment Interview, CBCL Child Behaviour Checklist, primary contact child’s individual primary contact at the institution. *The category “not able to contact” was used if institutional staff did not respond to repeated approaches about participation over a period of several months. **There were no significant differences between participating and non-participating RYC institutions with regard to geography and ownership
Sample characteristics of the adolescents participating in the study
| Characteristics |
| % |
| SD | Range |
|---|---|---|---|---|---|
| Gender | |||||
| Male | 170 | ||||
| Female | 230 | ||||
| Age | |||||
| Male | 16.5 years | 1.5 years | 12.2–19.3 | ||
| Female | 16.9 years | 1.2 years | 13.5–20.2 | ||
| Ethnic origin | |||||
| Norwegian | 307 | 78.5 | |||
| 1st generation immigrant | 54 | 13.8 | |||
| 2nd generation immigrant | 23 | 5.9 | |||
| Unaccompanied minor with asylum in Norway | 7 | 1.8 | |||
| Number of placement in the total sample |
|
|
|
| |
| Number of placements (by decision of the child welfare system) | |||||
| 1 | 69 | 19 | |||
| 2 | 96 | 26.4 | |||
| 3–5 | 150 | 41.2 | |||
| >5 | 49 | 13.4 | |||
| Age at first placement in the total sample |
|
|
|
| |
| Age at first placement (by decision of the child welfare system) | |||||
| 0–2 years | 18 | 4.6 | |||
| 3–5 years | 15 | 3.9 | |||
| 6–12 years | 98 | 25 | |||
| 13–16 years | 233 | 59.4 | |||
| 16–23 years | 28 | 7.1 | |||
| Placement in RYC | |||||
| Voluntary | 171 | 43.6 | |||
| Involuntary | 221 | 56.43 | |||
| Daytime activities | |||||
| School | 272 | 69.2 | |||
| Work | 15 | 3.8 | |||
| Work praxis | 30 | 7.5 | |||
| Neither school or work | 70 | 19.5 | |||
| Parental problems | |||||
| Mother chronic illness | 85 | 22.8 | |||
| Mother mental illness | 136 | 36 | |||
| Mother drug use | 36 | 9.6 | |||
| Father chronic illness | 64 | 17.9 | |||
| Father mental illness | 67 | 19.0 | |||
| Father drug use | 43 | 11.8 | |||
Total samples are indicated in bold
Comparison of participants versus non-participants on eight CBCL subscales
| Anxious/depressed | Withdrawn/depressed | Somatic complaints | Social problems | Thought problems | Attention problems | Rule breaking | Aggressive behaviour | |
|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
| Participants ( | 6.6 (4.9) | 4.7 (3.2) | 4.1 (3.8) | 4.6 (3.7) | 4.4 (3.8) | 7.3 (4.2) | 9.4 (6.0) | 10.3 (7.8) |
| Nonparticipants ( | 7.2 (5.1) | 5.6 (3.1) | 3.8 (3.8) | 5.3 (3.8) | 5.4 (4.6) | 8.6 (4.1) | 10.8 (7.0) | 12.2 (8.1) |
|
| 0.218 |
| 0.516 | 0.079 |
|
|
|
|
| Effect size ( | 0.05 | 0.12 | 0.02 | 0.07 | 0.11 | 0.13 | 0.09 | 0.11 |
| Range of subscale | 0–26 | 0–16 | 0–22 | 0–22 | 0–30 | 0–20 | 0–34 | 0–36 |
OR in bold = p < 0.05
* r = 0.10–0.30 = small effect
Observed 3-month prevalence of psychiatric DSM-IV disorders in percentages (95 % confidence interval) according to gender, age and voluntary vs. involuntary placement status
|
| Observedb prevalence % ( | Estimatedc prevalence % ( | Gendera | Agea | Placement statusa | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boys % | Girls % | OR, | 12–16 % | 17–21 % | OR, | Voluntary % | Involuntary % | OR, | ||||
| AS | 323 | 23.2 (18.9–28.1) | 24.4 | 26.3 (19.6–34.4) | 21.1 (15.8–27.4) | 1.3, | 22.5 (16.7–29.6) | 23.9 (18.0–31.0) | 1.1, | 19.4 (13.7–26.7) | 26.7 (20.7–33.7) | 1.5, |
| ADHD (CAPA) | 382 | 13.4 (10.3–17.1) | – | 15.5 (10.7–21.9) | 11.8 (8.2–16.7) | 1.4, | 13.7 (9.6–19.2) | 13.0 (8.9–18.6) | 0.9, | 12.8 (8.5–18.8) | 13.3 (9.4–18.6) | 1.1, |
| Clinical ADHD/treatment | 399 | 24.8 (20.8–29.3) | – | 27.6 (21.5–34.8) | 22.7 (17.7–28.6) | 1.3, | 26.1 (20.6–32.5) | 23.4 (18.0–29.9) | 0.9, | 25.1 (19.2–32.1) | 24.5 (19.3–30.6) | 1.0, |
| ADHD total | 399 | 32.3 (27.9–37.1) | 33.1 | 37.1 (30.2–44.5) | 28.8 (23.3–35.0) | 1.4, | 31.4 (25.5–38.0) | 33.3 (27.0–40.3) | 1.1, | 32.2 (25.6–39.5) | 32.7 (26.9–39.2) | 1.0, |
| CD | 335 | 19.1 (15.2–23.6) | 17.9 | 28.8 (21.9–36.8) | 12.2 (8.4–17.6) |
| 21.7 (16.1–28.5) | 16.6 (11.7–22.9) | 0.7, | 9.7 (5.8–15.5) | 26.4 (20.5–33.2) |
|
| ODD | 335 | 3.0 (1.6–5.4) | 2.2 | 1.4 (0.3–5.1) | 4.1 (2.1–7.8) | 0.3, | 3.6 (1.7–7.7) | 2.4 (0.9–5.9) | 0.6, | 2.8 (1.1–6.9) | 3.3 (1.5–7.0) | 1.2, |
| RAD | 323 | 21.1 (17.6–25.8) | 23.7 | 18.0 (12.4–25.4) | 23.2 (17.7–29.7) | 0.7, | 23.8 (17.8–30.9) | 18.4 (13.2–25.1) | 0.7, | 16.5 (11.3–23.6) | 25.6 (19.7–32.5) | 1.7, |
| Substance abuse | 335 | 11.9 (8.9–15.9) | 12.0 | 12.2 (7.7–18.7) | 11.7 (7.9–17.0) | 1.0, | 12.7 (8.4–18.6) | 11.2 (7.3–16.9) | 0.9, | 9.7 (5.8–15.6) | 14.3 (9.9–20.1) | 1.6, |
| Substance dependence | 335 | 2.7 (1.4–5.0) | 2.6 | 0.7 (0.1–4.0) | 4.1 (2.1–7.8) | 0.2, | 2.4 (0.9–6.0) | 3.0 (1.3–6.7) | 1.2, | 2.8 (1.1–6.9) | 2.7 (1.2–6.3) | 1.0, |
| MDD | 335 | 23.3 (19.1–28.1) | 21.6 | 10.8 (6.6–17.0) | 32.1 (26.0–39.0) |
| 24.7 (18.8–31.8) | 21.9 (16.3–28.7) | 0.9, | 20.7 (14.9–28.0) | 25.3 (19.5–32.1) | 1.3 |
| Dysthymiad | 335 | 30.1 (25.5–35.3) | 29.0 | 14.4 (9.5–21.2) | 41.3 (34.6–48.3) |
| 31.3 (24.7–38.7) | 29.0 (22.7–36.2) | 0.9, | 24.8 (18.5–32.4) | 33.5 (27.1–40.7) | 1.5, |
| Depression NOS | 335 | 24.8 (20.5–29.7) | 22.7 | 16.5 (11.3–23.6) | 30.6 (24.6–37.3) |
| 28.3 (22.0–35.6) | 21.3 (15.8–28.1) | 0.7, | 20.0 (14.3–27.2) | 27.5 (21.5–34.4) | 1.5, |
| Bipolar disorder | 334 | 0.6 (0.1–2.0) | 0.6 | 0.0 (0–0) | 1.0 (0.3–3.7) | 0.0, | 0.0 (0–0) | 1.2 (0.3–4.2) | 0.0, | 0.7 (0.1–3.8) | 0.5 (0.1–3.0) | 0.8, |
| MDD, dep NOS or dysthymiae | 335 | 37.0 (32.0–42.3) | – | 22.3 (16.2–29.3) | 47.4 (40.6–54.4) |
| 39.2 (32.1–46.7) | 34.9 (28.1–42.4) | 0.8, | 30.3 (23.4–38.3) | 41.8 (34.8–49.0) | 1.6, |
| AG without panic | 333 | 12.6 (9.5–16.6) | 12.9 | 8.7 (5.0–14.6) | 15.4 (11.0–21.1) | 0.5, | 10.4 (6.6–16.0) | 14.8 (10.2–20.9) | 1.5, | 11.0 (6.9–17.2) | 13.9 (9.6–19.7) | 1.3, |
| Panic without AG | 333 | 3.9 (3.3.–6.6) | 3.5 | 0.0 (0.0–0.0) | 6.7 (3.9–11.1) | 0.0, | 4.9 (2.5–9.3) | 3.0 (1.3–6.7) | 0.6, | 2.8 (1.1–6.9) | 5.0 (2.7–9.2) | 1.9, |
| Panic with AG | 333 | 0.9 (0.3–2.6) | 0.9 | 0.0 (0.0–0.0) | 1.5 (0.5–4.4) | 0.0, | 0.6 (0.1–3.4) | 1.2 (10.2–20.9) | 1.9, | 0.7 (0.1–3.8) | 1.1 (0.3–4.0) | 1.6, |
| Specific phobia | 335 | 6.3 (4.1–9.4) | 5.9 | 3.6 (1.5–8.1) | 8.2 (5.0–12.8) | 0.4, | 5.4 (2.9–10.0) | 7.1 (4.1–12.0) | 1.3, | 6.2 (3.3–11.4) | 6.0 (3.4–10.5) | 1.0, |
| Social phobia | 335 | 12.5 (9.4–16.5) | 13.7 | 7.2 (4.0–12.7) | 16.3 (11.8–22.1) |
| 12.0 (7.9–17.9) | 13.0 (8.8–18.9) | 1.1, | 12.4 (8.0–18.8) | 12.6 (8.6–18.2) | 1.0, |
| OCD | 335 | 3.6 (2.1–6.2) | 3.1 | 2.2 (0.7–6.2) | 4.6 (2.4–8.4) | 0.5, | 2.4 (0.9–6.0) | 4.7 (2.4–9.1) | 2.0, | 4.1 (2.9–8.7) | 3.3 (1.5–7.0) | 0.8, |
| PTSD | 335 | 0.6 (0.2–2.2) | 0.4 | 0.7 (0.1–3.9) | 0.5 (0.09–2.8) | 1.4, | 0.6 (0.1–3.3) | 0.6 (0.1–3.3) | 1.0, | 0.7 (0.1–3.8) | 0.5 (0.1–3.0) | 0.8, |
| GAD | 335 | 20.9 (16.9–25.6) | 20.7 | 15.1 (10.0–21.9) | 25.0 (19.5–31.5) |
| 21.1 (15.6–27.9) | 20.7 (15.3–27.4) | 1.0, | 15.9 (10.8–22.7) | 25.3 (19.5–32.1) |
|
| Bulimia | 335 | 0.9 (0.3–2.5) | 0.7 | 0.0 (0–0) | 1.5 (0.5–4.4) | 0.0, | 1.2 (0.3–4.3) | 0.6 (0.1–3.3) | 0.5, | 1.4 (0.4–4.9) | 0.5 (0.1–3.0) | 0.4, |
| Any anxiety disorder | 335 | 34.0 (29.2–39.2) | – | 25.9 (19.3–33.7) | 39.8 (33.2–46.8) |
| 31.3 (24.7–38.7) | 36.7 (29.8–44.2) | 1.2, | 26.2 (19.7–33.9) | 40.1 (33.3–47.4) |
|
| Any disorder |
|
|
| 73.7 (65.6–80.0) | 77.9 (71.5–83.2) | 0.8, | 76.9 (69.7–82.7) | 75.5 (68.3–81.4) | 0.9, | 68.3 (60.2–75.4) | 81.8 (75.4–86.8) |
|
OR in bold = p < 0.05
Estimated prevalence of missing cases inclusive of non-participants (N = 541)
AS Asperger’s syndrome, ADHD (CAPA) attention deficit disorder as obtained by CAPA interview, clinical ADHD/treatment, diagnosis set before the current study by a specialist in child psychiatry or paediatrics and/or presently medicated for ADHD, ODD oppositional defiant disorder without CD exclusion, CD conduct disorder, RAD reactive attachment disorder, MDD major depressive disorder, dep NOS depressive disorder not otherwise specified, GAD generalized anxiety disorder, panic with AG agoraphobia, OCD obsessive compulsive disorder, PTSD post-traumatic stress disorder; substance abuse and dependency do not include tobacco
aCalculations for age, gender and placement status were based on observed prevalence. Parameter coding for girls = 0, boys = 1; 12–16 years = 0, 17–21 years = 1; voluntary = 0, involuntary = 1
bObserved prevalence was calculated based on complete case information of N = 323–399 participants
cEstimation by multiple imputation (MI) for N = 541 was based on maximum available information for each participant and 141 non-participants. (CIs not available with MI in Mplus)
dDysthymia prevalence rate was calculated without duration criteria
eDysthymia prevalence rate was calculated according to DSM-IV 1 year duration criteria
Comorbidity between common diagnostic categories. Prevalence (percent) and odds ratio (OR) (95 CI), N = 323
| Any affective disorder | Any anxiety disorder | ADHD | Any disruptive behaviour disorder | Any substance disorder | |
|---|---|---|---|---|---|
| Any affective disorder |
| 59.8 %
| 35.2 % 1.3 (0.8–2.1) | 29.5 %
| 17.2 % 1.8 (0.9–3.4) |
| Any anxiety disorder | 63.5 %
|
| 33.0 % 1.1(0.7–1.8) | 28.7 %
| 18.3 %
|
| ADHD | 42.2 % 1.3 (0.8–2.1) | 37.3 % 1.1 (0.7–1.8) |
| 29.4 %
| 15.7 % 1.4 (0.7–2.7) |
| Any disruptive behaviour disorder | 52.2 %
| 47.8 %
| 43.5 %
|
| 31.9 %
|
| Any substance disorder | 50.0 % 1.8 (0.9–3.4) | 50.0 %
| 38.1 % 1.4 (0.7–2.7) | 52.5 %
|
|
OR in bold = p < 0.05